HYMPAVZI is currently approved in more than 40 countries for the treatment of eligible patients 12 years of age and older living with hemophilia A without factor VIII inhibitors, or hemophilia B ...

Pfizer presents positive results from phase 3 BASIS study of Hympavzi in adults and adolescents with haemophilia A or B with inhibitors at ASH meeting: New York Tuesday, December ...

Research ; A drop of blood to detect strokes and head trauma. In neurological emergencies, every minute counts. Stroke treatment must ideally be administered within four hours of ...

Overreliance on D-dimer testing and similarity to other conditions may mean pulmonary embolism or venous thromboembolism is ...

RRB Group D Mock Test 2025: The Railway Recruitment Board has released the mock test for candidates to evaluate their current performance, spot weak areas, and improve their accuracy and speed before ...

Low levels of vitamin D seem to raise your risk of heart attack but scientists are still figuring out why—and whether ...

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes.

A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...

Scientists at Northern Arizona University are developing a promising new way to detect Alzheimer’s disease earlier than ever before—by tracking how the brain uses sugar. Using tiny particles in the ...

Platelet-to-Lymphocyte Ratio (PLR): Elevated PLR is another key marker linked to more aggressive tumor characteristics, such ...

Scientists at Northwestern University have developed the fastest test yet for diagnosing hepatitis C virus (HCV). The highly ...